Engineered hormone receptors for monitoring hormones

WO2026085264A2PCT designated stage Publication Date: 2026-04-23UNIV OF WASHINGTON
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
UNIV OF WASHINGTON
Filing Date
2025-10-15
Publication Date
2026-04-23

Smart Images

  • Figure US2025051141_23042026_PF_FP_ABST
    Figure US2025051141_23042026_PF_FP_ABST
Patent Text Reader

Abstract

An example engineered hormone receptor includes a ligand binding domain (LBD) that specifically binds a hormone and a tag inserted between a first segment of the LBD and a second segment of the LBD. The first segment includes a 1st to 11th alpha helix of the LBD and the second segment includes a 12th alpha helix of the LBD. A first linker is inserted between the tag and the 11th alpha helix in the first segment of the LBD. A second linker is inserted between the tag and the 12th alpha helix in the second segment of the LBD.
Need to check novelty before this filing date? Find Prior Art